Justin Fleming, DPM
Podiatrist · Somerset, NJNPI 1043319122
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.1%), royalties or licence payments and consulting fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 99.4% of it on its own, with 14 other manufacturers making up the rest. Among podiatrist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 921 payments — averaging $1341.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1.2M
- Seapearl East, Inc$3K
- Stryker$3K
- Paragon 28, Inc.$312
- Exactech, Inc.$175
- Pinnacle, Inc$121
- plus $581 from 9 others
What the payments were for
- Royalty or licence$491,09740%
- Consulting fees$170,99414%
- Speaking & faculty fees$507,66141%
- Travel & lodging$49,8194%
- Food & beverage$11,8741%
- Education$3,6990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 858 | $1,228,301 |
| Seapearl East, Inc | 14 | $3,050 |
| Stryker(2 entities) | 34 | $2,605 |
| Paragon 28, Inc. | 2 | $312 |
| Exactech, Inc. | 1 | $175 |
| Pinnacle, Inc | 1 | $121 |
| Eclipse Technology Solutions Inc. | 2 | $118 |
| Organogenesis Inc. | 1 | $106 |
| Cerapedics Inc. | 1 | $99 |
| Impactortho, Inc. | 1 | $81 |
| Johnson & Johnson | 2 | $53 |
| Acumed LLC | 1 | $51 |
| Kerecis Limited | 1 | $44 |
| Globus Medical | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$2,070,899
- DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE ANKLE FRACTURE$46,652
- DISTAL EXTREMITIES IMPLANTS TRAUMA ANKLE FRACTURE$17,994
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE IB LIGAMENT AUGMENTATION$8,086
- DISTAL EXTREMITIES IMPLANTS IB LIGAMENT AUGMENTATION OTHER$4,190
- DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE EXTERNAL FIXATION$1,075
- DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE DISTAL TIBIA$860
- DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS MIDFOOT SCREWS$860
- DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS CFS$860
- DISTAL EXTREMITIES INSTRUMENTS TRAUMA HINDFOOT & ANKLE TRAUMA$645
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE SPEEDBRIDGE$645
- DISTAL EXTREMITIES IMPLANTS TRAUMA EXTERNAL FIXATION$645
- INFINITY$506
- INBONE$475
- DISTAL EXTREMITIES IMPLANTS DYNANITE OTHER$430
- DISTAL EXTREMITIES IMPLANTS TIGHTROPE SYNDESMOSIS$215
- DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS BIOSYNC WEDGES$215
- DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS TMT PLATES$215
- DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE MTP$215
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE SUTURETAKS & FASTAKS$215
How this compares
$1,235,144 in reported general payments places this provider in the 95th percentile of 382 podiatrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 62 | $31,973 |
| Oxycodone Hcl | 105 | $502 |
| Meloxicam | 115 | $269 |
| Gabapentin | 42 | $207 |
| Cephalexin | 14 | $59 |
| Tizanidine Hcl | 15 | $50 |
| Tramadol Hcl | 23 | $44 |
| Amoxicillin | 14 | $12 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $53 | $31,97362 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 382 podiatrist providers in New Jersey.
Other podiatrist in Somerset
- Eric BaskinManahawkin$298K
- Jonathan RichardsEnglewood$79K
- Jack BondiSewell$53K
- Matthew WohlgemuthHammonton$49K
- Ritchard RosenEnglewood$44K
- Michael HuchitalLyndhurst$41K
- Jeffrey GewirtzPark Ridge$24K
- James SullivanSea Girt$19K
- Georgios KotziasParamus$19K
- Charles MarcheseManalapan$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.